Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

THE TRUTH ABOUT: Sonoma pharma expands its partner network for oral dental products in us china - Caught on Camera

Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) has added Salus Medical as an additional distribution partner in the U.S for dental care.

  • The Company has also expanded its oral and dental care lines to China via a partnership deal with Anlicare International.
  • Sonoma entered into a non-exclusive agreement with Salus Medical to distribute Endocyn root canal irrigant through their existing dental channels. 
  • In addition, Salus Medical will expand on its dermatology offerings with Sonoma's Microcyn RX and Regenacyn Plus products and have non-exclusive distribution rights for Microcyn wound care products.
  • Additionally, Sonoma and Anlicare agreed to cooperate to complete the regulatory work necessary to obtain licenses in China to distribute Sonoma's Microcyn technology-based dental and oral products. 
  • Anlicare will bear the regulatory costs, and in return, Sonoma agreed to grant Anlicare exclusive rights for selling and distributing oral and dental care products in China.
  • In September, Sonoma launched its first OTC products in the U.S. on Amazon and a new consumer-focused product on Amazon in Europe.
  • Price Action: SNOA shares are down 12.2% at $3.73 during the premarket session on the last check Friday.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.